Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Canna Law Blog

MARCH 4, 2020

With respect to ketamine infusion therapy (which is the prime time attraction of ketamine clinics), the medical research based promise is for treatment of chronic neuropathic pain, chronic pain (instead of opioids), and various medication-resistant mental health disorders, including depression, bi-polar disorder, and PTSD (among others).

Therapy 102

Therapy Legalization Chronic Pain DEA 102

SpeedWeed

MARCH 21, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. But there are potential safety concerns.

Research and Development 40

Research and Development Hydroponic DEA Cannabinoids 40

Cannabis Law Report

JULY 1, 2021

On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?

Law 81

Law Research and Development Therapy DEA 81

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas.

Research and Development 81

Research and Development DEA Programs State Laws 81

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Project CBD

AUGUST 23, 2023

8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .”

Cannabinoids 142

Cannabinoids Hemp THC Safety 142

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. In August 2018, reports of shops being raided and CBD product confiscated began to circulate on Twitter.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

APRIL 21, 2022

MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices. The safety and efficacy of MDMA-assisted therapy is currently under investigation. The full statement. Nair, Ph.D., Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

SpeedWeed

MARCH 21, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. But there are potential safety concerns.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. But there are potential safety concerns.

DEA 52

DEA Cannabinoids Research and Development THC 52

Cannabis Law Report

JUNE 8, 2021

The Minnesota Hemp Association, now rebranded as the Minnesota Cannabis Association is a 501(c)(4) organization providing advocacy, education, business development opportunities to advance the growth and vitality of Minnesota’s cannabis industry from seed to sale. Minnesota Hemp Association updates goals along with its name.

Hemp 78

Hemp Seed-To-Sale Food Research and Development 78

Cannabis Law Report

JULY 28, 2022

Testimonies During The House Agriculture Subcommittee On Biotechnology, Horticulture, And Research Addressed FDA Inaction on CBD and Intoxicating Hemp Derivatives. An Examination of the USDA Hemp Production Program. Washington D.C. Today, U.S. That reluctance, in turn, has dampened industry demand for harvested hemp material.”. “In

Agriculture 52

Agriculture Hemp CBD Research and Development 52

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Cannabis Law Report

APRIL 13, 2022

North American Industry Leader in Psychedelic Therapy and Research. Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Watch Video: The Press Release. NEWS PROVIDED BY. Numinus Wellness Inc. .

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

AUGUST 6, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q1 2022 declined by 17% versus Q1 2021, driven by year-over-year reductions in General & Administrative (“G&A”) and Research and Development (“R&D”) expenses partially offset by an increase in Sales & Marketing (“S&M”) expenses. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. This process should also ensure appropriate funding allocated for this research.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Research suggests that about one in five people will have an increase in paranoia as a result of the delta-9 THC after consuming cannabis.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JUNE 1, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q4 2021 declined by 25% versus Q4 2020, driven by year-over-year reductions in Sales & Marketing, and Research and Development (“R&D”) expenses. Drug Enforcement Administration (the “DEA”), the U.S. hemp industry in the U.S.,

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 14, 2022

Although research is still underway, the effects of both short- and long-term exposure to pesticides by consuming (i.e., Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures.

Environment 52

Environment Agriculture Compliance Compliance 52

SpeedWeed

MARCH 7, 2021

We also speak with Mark Diener, Senior Product Manager of JULABO USA , which manufactures liquid temperature control instrumentation for the cannabis and hemp industries as well as for research, science, laboratories, pilot plants, and industrial processes. Is it cost savings, increased sales, less waste, safety, all the above?

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

MAY 1, 2019

For a business which has decided to publish ads for cannabis businesses, there are a number of steps that would minimize the risk of receiving a call from a federal prosecutor or a visit from your local DEA agent. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof. Code § 26032. 2 Ajax Letter.

Legalization 45

Legalization Business Law Cannabis 45

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 93

DEA Research and Development Cultivation Supply Chain 93

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). if the plant is moved to Schedule III.

Research and Development 126

Research and Development DEA Marijuana Pharmaceutical 126

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Some programs also provide a comprehensive host of resources on a website or app.

Therapy 78

Therapy Access Blood Pressure Treatment 78

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. The safety of using these products however, is still unknown. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock). But there’s very little research on that, and it’s mostly based on anecdotal evidence.

THC 98

THC Research and Development Cannabinoids CBD 98

Canna Law Blog

MARCH 4, 2020

With respect to ketamine infusion therapy (which is the prime time attraction of ketamine clinics), the medical research based promise is for treatment of chronic neuropathic pain, chronic pain (instead of opioids), and various medication-resistant mental health disorders, including depression, bi-polar disorder, and PTSD (among others).

Legalization 55

Legalization Therapy Chronic Pain DEA 55

The Blunt Truth

MAY 15, 2020

We’ve got an update on the latest Montana legalization developments. marijuana research. We reported last week on the DOJ’s memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. SBA funds, however, are not. montana update. montana update.

Banking 106

Banking Research and Development Programs Advocacy 106

Cannabis Law Report

SEPTEMBER 19, 2019

As far as we know, Senate Majority Leader Mitch McConnell still isn’t willing to make even the slightest move toward legal weed; however, there have been some wicked, unforeseen developments. . Doctors say they look forward to seeing more research on the subject as more states allow marijuana in smokable form. hemp and marijuana.

Vaping 55

Vaping Hemp Education Patients 55